Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Mead

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Blood|July 9, 2008
Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic diseaseAdam J Mead, Rosemary E Gale, Robert K Hills, et al.
Open Heart|October 17, 2025
Causal relevance of clonal haematopoiesis with cardiac disease and adverse remodelling: a Mendelian randomisation studyAlec Peter Morley, Maddalena Ardissino, Paul Carter, et al.
Hemasphere|July 11, 2020
Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With MyelofibrosisNikolaos Sousos, Gemma Buck, Alba Rodriguez-Meira, et al.
The Journal of Experimental Medicine|February 5, 2014
Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fateAmit Grover, Elena Mancini, Susan Moore, et al.
Blood Advances|July 25, 2020
Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patientsKorsuk Sirinukunwattana, Alan Aberdeen, Helen Theissen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2020
An ontogenetic switch drives the positive and negative selection of B cellsXijin Xu, Mukta Deobagkar-Lele, Katherine R Bull, et al.
British Journal of Haematology|August 21, 2018
Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UKNicholas C P Cross, Helen E White, Paul A S Evans, et al.
Cancer|May 2, 2022
Defining disease modification in myelofibrosis in the era of targeted therapyNaveen Pemmaraju, Srdan Verstovsek, Ruben Mesa, et al.
British Journal of Haematology|March 12, 2019
UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPNClaire Harrison, Jonathan Mathias, Maz Campbell-Drew, et al.
Ejhaem|September 2, 2022
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UKLewis Carpenter, Patrick Rockenschaub, Grace B Hatton, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Blood|July 9, 2008
Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic diseaseAdam J Mead, Rosemary E Gale, Robert K Hills, et al.
Open Heart|October 17, 2025
Causal relevance of clonal haematopoiesis with cardiac disease and adverse remodelling: a Mendelian randomisation studyAlec Peter Morley, Maddalena Ardissino, Paul Carter, et al.
Hemasphere|July 11, 2020
Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With MyelofibrosisNikolaos Sousos, Gemma Buck, Alba Rodriguez-Meira, et al.
The Journal of Experimental Medicine|February 5, 2014
Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fateAmit Grover, Elena Mancini, Susan Moore, et al.
Blood Advances|July 25, 2020
Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patientsKorsuk Sirinukunwattana, Alan Aberdeen, Helen Theissen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2020
An ontogenetic switch drives the positive and negative selection of B cellsXijin Xu, Mukta Deobagkar-Lele, Katherine R Bull, et al.
British Journal of Haematology|August 21, 2018
Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UKNicholas C P Cross, Helen E White, Paul A S Evans, et al.
Cancer|May 2, 2022
Defining disease modification in myelofibrosis in the era of targeted therapyNaveen Pemmaraju, Srdan Verstovsek, Ruben Mesa, et al.
British Journal of Haematology|March 12, 2019
UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPNClaire Harrison, Jonathan Mathias, Maz Campbell-Drew, et al.
Ejhaem|September 2, 2022
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UKLewis Carpenter, Patrick Rockenschaub, Grace B Hatton, et al.
Pageof 13